Cite
HARVARD Citation
Abdullahi, S. et al. (2022). Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial. Lancet. 9 (1), pp. e26-e37. [Online].